Blue light therapy could drain abscesses faster
NCT ID NCT06052956
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a light-activated blue dye treatment to standard abscess drainage can clear infection faster. About 120 adults with deep abscesses will get either standard drainage alone or drainage plus the dye treatment. The main goal is to see if the dye treatment shortens the time the drainage tube needs to stay in place.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults 18 years or older * All patients with clinical symptoms (ex: fever, chills, pain, tachycardia, hypotension), laboratory (leukocytosis) and radiologic findings (thick walled, rim-enhancing collection with gas bubbles or air-fluid levels) compatible with an abscess that requires image- guided percutaneous drainage * Approval by the primary care team to pursue PDT and discuss enrollment with the patient Exclusion Criteria: * Pregnancy * Lactation * Allergy to contrast media, narcotics, sedatives, atropine or eggs * Necrotic tissue that requires surgical debridement * Severely compromised cardiopulmonary function or hemodynamic instability * Thrombocytopenia (\<50,000/mm3) * Uncorrectable coagulopathy * Poor kidney function (serum creatinine \>3mg/dl) * Lack of a safe pathway to the abscess or fluid collection * Unable or unwilling to understand or to provide informed consent * Unable or unwilling to undergo study procedures * Patient unable to cooperate with, or to be positioned for the procedure * Unable to comply with necessary follow up * Patients with pancreatic abscesses * Patients with known fistulous communication with their abscess * Abscess greater than 13 cm in diameter
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Abscess are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Highland Hospital
Rochester, New York, 14620, United States
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.